Allelix BioPharmaceuticals, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Allelix BioPharmaceuticals, Inc..The latest application filed is for "production of human parathyroid hormone from microorganisms".
- Allelix BioPharmaceuticals, Inc. -
- Allelix Biopharmaceuticals Inc. - Mississauga CA
- Allelix Biopharmaceuticals, Inc. - Ontario CA
- Allelix Biopharmaceuticals, Inc. - Missisauga CA
Trademarks
| Patent | Date |
|---|---|
| Production of human parathyroid hormone from microorganisms App 20030228665 - Gautvik, Kaare M. ; et al. | 2003-12-11 |
| G protein coupled receptor A4 App 20030139589 - Zastawny, Roman | 2003-07-24 |
| Azaindoles having serotonin receptor affnity App 20010049441 - Edwards, Louise ; et al. | 2001-12-06 |
| Pyrrolidine-indole compounds having 5-HT.sub.6 affinity Grant 6,100,291 - Slassi , et al. August 8, 2 | 2000-08-08 |
| Mammalian EDG-5 receptor homologs Grant 6,057,126 - Munroe , et al. May 2, 2 | 2000-05-02 |
| 5-cyclo indole compounds Grant 5,998,438 - Slassi , et al. December 7, 1 | 1999-12-07 |
| N- methyl piperazine compounds having dopamine receptor affinity Grant 5,968,478 - Fu , et al. October 19, 1 | 1999-10-19 |
| Muscarinic receptor ligands Grant 5,849,734 - Tehim , et al. December 15, 1 | 1998-12-15 |
| Alkyl-substituted compounds having dopamine receptor affinity Grant 5,834,459 - Fu November 10, 1 | 1998-11-10 |
| Treatment of herpesvirus infection Grant 5,831,001 - Twist , et al. November 3, 1 | 1998-11-03 |
| 5-HT2 receptor ligands Grant 5,824,676 - Tehim , et al. October 20, 1 | 1998-10-20 |
| Anti-viral compositions Grant 5,674,849 - Twist , et al. October 7, 1 | 1997-10-07 |
| Alkyl-substituted compounds having dopamine receptor affinity Grant 5,602,121 - Fu February 11, 1 | 1997-02-11 |
| Benzyl-substituted compounds having dopamine receptor affinity Grant 5,602,120 - Fu , et al. February 11, 1 | 1997-02-11 |
| 5-HT2 receptor ligands Grant 5,602,124 - Tehim , et al. February 11, 1 | 1997-02-11 |
| Bone-stimulating, non-vasoactive parathyroid hormone variants Grant 5,599,792 - Kronis , et al. February 4, 1 | 1997-02-04 |
| 5-HT-1D receptor ligands Grant 5,504,101 - Glennon April 2, 1 | 1996-04-02 |
| Parathyroid hormone formulation Grant 5,496,801 - Holthuis , et al. March 5, 1 | 1996-03-05 |
| Antiviral polynucleotide conjugates Grant 5,495,006 - Climie , et al. February 27, 1 | 1996-02-27 |
| Method for isolating a soluble osteogenic factor from bone Grant 5,403,825 - Lagarde , et al. April 4, 1 | 1995-04-04 |
| Stability-enhanced variants of parathyroid hormone Grant 5,382,658 - Kronis , et al. January 17, 1 | 1995-01-17 |
| Ovarian cancer ascites factor, in isolated form Grant 5,326,690 - Xu , et al. July 5, 1 | 1994-07-05 |
| EGF variants and pharmaceutical use thereof Grant 5,218,093 - Guo , et al. June 8, 1 | 1993-06-08 |
| Isolated osteogenic factor Grant 5,169,837 - Lagarde , et al. December 8, 1 | 1992-12-08 |
| Treating inflammation with hepatocyte stimulating factor interferon .beta..sub.2 Grant 4,973,478 - Gauldie , et al. November 27, 1 | 1990-11-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 